The courses were led by the EVI and designed to strengthen capacity in vaccine research and development (R&D), with a particular focus on supporting professionals from low- and middle-income countries (LMICs).

World Malaria Day is observed every year on 25 April to recognise global efforts to control malaria.

The OPT-MVAC consortium will support the rollout of malaria vaccines in 14 Central and West African countries.

An inactivated Hepatitis C vaccine showing promising results in preclinical trials moves closer to human trials, with a new project to establish and optimise production and manufacture of the vaccine.

New EVI-led project will assess the impact of enhancing seasonal malaria vaccination in Guinea and Benin. The findings could shape future...

EVI launched Phase II clinical trial to evaluate the R21/Matrix-M malaria vaccine (by Univ. of Oxford), in women of childbearing potential.

March 24 marks World Tuberculosis Day on the anniversary of Dr. Robert Koch's groundbreaking discovery of Mycobacterium tuberculosis in 1882

From establishing a strong clinical trial network to accelerating vaccine research and fostering cross-border collaboration, VACCELERATE...

A newly published article outlines the protocol for new phase Ia/b clinical trial for the Invaplex AR-Detox  Shigella vaccine...